Search

Author/Creator Fullana, Marie

1. 211 Targeting BTN2A1 modulates anti-tumor activity of Vg9Vd2 T cells. (10th December 2020)

Authors:
Cano, Carla; Gassart, Aude de; Pasero, Christine; Gabriac, Melanie; Fullana, Marie; Granarolo, Emilie; Rene, HOET; Imbert, Caroline; Gorvel, Laurent; Briantais, Antoine; Floch, Anne-Charlotte Le; Olive, Daniel
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A126
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 211 Targeting BTN2A1 modulates anti-tumor activity of Vg9Vd2 T cells. (9th November 2020)

Authors:
Cano, Carla; Gassart, Aude de; Pasero, Christine; Gabriac, Melanie; Fullana, Marie; Granarolo, Emilie; Rene, HOET; Imbert, Caroline; Gorvel, Laurent; Briantais, Antoine; Floch, Anne-Charlotte Le; Olive, Daniel
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A230
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. FHR4‐based immunoconjugates direct complement‐dependent cytotoxicity and phagocytosis towards HER2‐positive cancer cells. Issue 12 (30th September 2019)

Authors:
Seguin‐Devaux, Carole; Plesseria, Jean‐Marc; Verschueren, Charlène; Masquelier, Cécile; Iserentant, Gilles; Fullana, Marie; Józsi, Mihály; Cohen, Jacques H. M.; Dervillez, Xavier
Journal:
Molecular oncology
Issue:
Volume 13:Issue 12(2019)
Page Start:
2531
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗